compounded glp-1 risks Medications (e.g. Semaglutide and Tirzepatide): Why South Africans Should Be Cautious A secret shopper study found

If you have been wondering why you are not losing weight after 4 weeks on semaglutide , medication storage should be one of the first variables you investigate

Johns wort may decrease the effectiveness of hormonal birth control, Dr

In January 2025, Novo Nordisk stated that the United States Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease progression, kidney failure (end-stage renal disease), and cardiovascular disease-related death in individuals with type 2 diabetes and chronic kidney disease (CKD)

Cortical GABAergic excitation contributes to epileptic activities around human glioma

Clinical Support This is where the platforms diverge most significantly